Method for producing latent curing agent

US9481787B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9481787-B2
Application numberUS-201113389356-A
CountryUS
Kind codeB2
Filing dateJul 13, 2011
Priority dateSep 17, 2010
Publication dateNov 1, 2016
Grant dateNov 1, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A latent curing agent formed by holding an imidazole compound in porous resin particles is produced by emulsifying an oil phase obtained by dissolving a polyfunctional isocyanate compound in an organic solvent in an amount of 1.5 to 5 times by mass the amount of polyfunctional isocyanate compound in an aqueous phase obtained by dissolving a water-soluble polypeptide and a surfactant in water, then subjecting the emulsion to interfacial polymerization, adding a proteolytic enzyme to carry out an enzyme degradation treatment, then recovering the porous resin particles, and making an imidazole compound solution permeate into the recovered porous resin particles.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for producing a latent curing agent in which an imidazole compound is held in porous resin particles obtained by interfacial polymerization of a polyfunctional isocyanate compound, the method comprising the following steps (A) to (E): Step (A) a step of obtaining an oil-in-water emulsion by emulsifying an oil phase obtained by dissolving a polyfunctional isocyanate compound in an organic solvent in an aqueous phase obtained by dissolving a water-soluble polypeptide and a surfactant in water; Step (B) a step of forming porous resin particles by interfacial polymerization of the polyfunctional isocyanate compound in the oil phase by heating the oil-in-water emulsion; Step (C) a step of carrying out an enzyme degradation treatment on the porous resin particles by adding a proteolytic enzyme into an interfacial polymerization solution in which the porous resin particles are dispersed; Step (D) a step of recovering the porous resin particles that have been subjected to the enzyme degradation treatment from the interfacial polymerization reaction solution; and Step (E) a step of acquiring a latent curing agent in which an imidazole compound is held in porous resin particles, by mixing the recovered porous resin particles with an imidazole compound solution obtained by dissolving an imidazole compound in an organic solvent, wherein the imidazole compound solution further includes a tertiary amine compound and the tertiary amine compound is present in an amount that is 0.1 to 0.8 times by mass an amount of the imidazole compound, to make the imidazole compound solution permeate into the porous resin particles. 2. The production method according to claim 1 , wherein in the step (A), the oil phase is obtained by dissolving the polyfunctional isocyanate compound in the organic solvent, the organic solvent being used in an amount that is 1.5 to 5 times by mass an amount of the polyfunctional isocyanate compound. 3. The production method according to claim 1 , wherein the water-soluble polypeptide is gelatin. 4. The production method according to claim 3 , wherein the gelatin used exhibits a jelly strength according to JIS K6503-2001 of 10 to 250. 5. The production method according to claim 1 , wherein the tertiary amine compound includes 2,4,6-tris(dimethylaminomethyl)phenol. 6. The production method according to claim 1 , wherein the tertiary amine is liquid. 7. The production method according to claim 6 , wherein the tertiary amine is selected from the group consisting of dimethylethanolamine, dimethylbenzylamine, 2,4,6-tris(dimethylaminomethyl)phenol, and 1,8-diazabicyclo[5.4.0]undecene. 8. A thermosetting resin composition comprising the latent curing agent obtained by the production method according to claim 1 , and a thermosetting resin. 9. The thermosetting resin composition according to claim 8 , wherein the thermosetting resin is a thermosetting epoxy resin. 10. An anisotropic conductive adhesive film formed by dispersing conductive particles for anisotropic conductive connection in the thermosetting resin composition according to claim 8 , and then forming the resultant dispersion into a film. 11. An adhesive film for a solar battery obtained by forming the thermosetting resin composition according to claim 8 into a film. 12. A method for producing a latent curing agent in which an imidazole compound is held in porous resin particles obtained by interfacial polymerization of a polyfunctional isocyanate compound, the method comprising the following steps (A) to (E): Step (A) a step of obtaining an oil-in-water emulsion by emulsifying an oil phase obtained by dissolving a polyfunctional isocyanate compound in an organic solvent in an aqueous phase obtained by dissolving a water-soluble polypeptide and a surfactant in water; Step (B) a step of forming porous resin particles by interfacial polymerization of the polyfunctional isocyanate compound in the oil phase by heating the oil-in-water emulsion; Step (C) a step of carrying out an enzyme degradation treatment on the porous resin particles by adding a proteolytic enzyme into an interfacial polymerization solution in which the porous resin particles are dispersed; Step (D) a step of recovering the porous resin particles that have been subjected to the enzyme degradation treatment from the interfacial polymerization reaction solution; and Step (E) a step of acquiring a latent curing agent in which an imidazole compound is held in porous resin particles, by mixing the recovered porous resin particles with an imidazole compound solution obtained by dissolving an imidazole compound in an organic solvent to make the imidazole compound solution permeate into the porous resin particles, wherein the imidazole compound includes two kinds of imidazole compound comprising 2-methylimidazole and a second imidazole compound having a melting point equal to or lower than the melting point of 2-methylimidazole. 13. The production method according to claim 12 , wherein the second imidazole compound comprises 2-ethyl-4-methylimidazole or 2-phenylimidazole.

Assignees

Inventors

Classifications

  • for the production of solar panels · CPC title

  • Supporting structures for PV modules · CPC title

  • Adhesives based on epoxy resins; Adhesives based on derivatives of epoxy resins · CPC title

  • Masked aromatic polyisocyanates · CPC title

  • Polyhydroxy compounds · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9481787B2 cover?
A latent curing agent formed by holding an imidazole compound in porous resin particles is produced by emulsifying an oil phase obtained by dissolving a polyfunctional isocyanate compound in an organic solvent in an amount of 1.5 to 5 times by mass the amount of polyfunctional isocyanate compound in an aqueous phase obtained by dissolving a water-soluble polypeptide and a surfactant in water, t…
Who is the assignee on this patent?
Kamiya Kazunobu, Dexerials Corp
What technology area does this patent fall under?
Primary CPC classification C08G59/4014. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Nov 01 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).